SABCS 2017: lifestyle factors, hormone receptor-positive advanced disease, liquid biopsies, and prognosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-5076
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
SABCS 2017: lifestyle factors, hormone receptor-positive advanced disease, liquid biopsies, and prognosis ; volume:11 ; number:3 ; day:21 ; month:8 ; year:2018 ; pages:208-212 ; date:9.2018
Magazine of European Medical Oncology ; 11, Heft 3 (21.8.2018), 208-212, 9.2018
- Creator
-
Rinnerthaler, Gabriel
- Contributor
-
Gampenrieder, Simon Peter
Greil, Richard
SpringerLink (Online service)
- DOI
-
10.1007/s12254-018-0433-x
- URN
-
urn:nbn:de:101:1-2018102723341600391173
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rinnerthaler, Gabriel
- Gampenrieder, Simon Peter
- Greil, Richard
- SpringerLink (Online service)
Other Objects (12)
Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer
Rat Models of Hormone Receptor-Positive Breast Cancer
Immunotherapy for hormone receptor‒positive HER2-negative breast cancer
Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
EndoPredict® in early hormone receptor-positive, HER2-negative breast cancer
Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
PTEN promoter methylation predicts 10-year prognosis in hormone receptor-positive early breast cancer patients who received adjuvant tamoxifen endocrine therapy
Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization
Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
Comparative biological activity of palbociclib and ribociclib in hormone receptor-positive breast cancer
Liquid biopsies in epilepsy: biomarkers for etiology, diagnosis, prognosis, and therapeutics
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer
Rat Models of Hormone Receptor-Positive Breast Cancer
Immunotherapy for hormone receptor‒positive HER2-negative breast cancer
Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
EndoPredict® in early hormone receptor-positive, HER2-negative breast cancer
Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
PTEN promoter methylation predicts 10-year prognosis in hormone receptor-positive early breast cancer patients who received adjuvant tamoxifen endocrine therapy
Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization
Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
Comparative biological activity of palbociclib and ribociclib in hormone receptor-positive breast cancer
Liquid biopsies in epilepsy: biomarkers for etiology, diagnosis, prognosis, and therapeutics
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer
Rat Models of Hormone Receptor-Positive Breast Cancer
Immunotherapy for hormone receptor‒positive HER2-negative breast cancer
Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
EndoPredict® in early hormone receptor-positive, HER2-negative breast cancer
Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
PTEN promoter methylation predicts 10-year prognosis in hormone receptor-positive early breast cancer patients who received adjuvant tamoxifen endocrine therapy
Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization
Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
Comparative biological activity of palbociclib and ribociclib in hormone receptor-positive breast cancer
Liquid biopsies in epilepsy: biomarkers for etiology, diagnosis, prognosis, and therapeutics